BioInvent International (Sweden) Analysis
BINV Stock | SEK 44.20 0.30 0.68% |
BioInvent International AB is overvalued with Real Value of 37.47 and Hype Value of 44.2. The main objective of BioInvent International stock analysis is to determine its intrinsic value, which is an estimate of what BioInvent International AB is worth, separate from its market price. There are two main types of BioInvent International's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect BioInvent International's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of BioInvent International's stock to identify patterns and trends that may indicate its future price movements.
The BioInvent International stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. BioInvent International is usually not traded on NationalDay, International Workers ' Day, St . John 's Day, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday. BioInvent Stock trading window is adjusted to Europe/Stockholm timezone.
BioInvent |
BioInvent Stock Analysis Notes
About 57.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.4. Some equities with similar Price to Book (P/B) outperform the market in the long run. BioInvent International recorded a loss per share of 4.56. The entity had not issued any dividends in recent years. The firm had 1:25 split on the 14th of December 2020. BioInvent International AB focuses on the research and development of immunomodulating antibodies for the treatment of cancer in Sweden, Europe, and internationally. The Company was founded in 1997 and is based in Lund, Sweden. BioInvent International operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 68 people. For more info on BioInvent International AB please contact Martin Welschof at 46 4 62 86 85 50 or go to https://www.bioinvent.com.BioInvent International Investment Alerts
BioInvent International had very high historical volatility over the last 90 days | |
The company reported the revenue of 19.38 M. Net Loss for the year was (278.44 M) with profit before overhead, payroll, taxes, and interest of 19.38 M. | |
BioInvent International AB has accumulated about 28.46 M in cash with (245.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08. | |
Roughly 57.0% of the company shares are held by institutions such as insurance companies |
BioInvent Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.99 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioInvent International's market, we take the total number of its shares issued and multiply it by BioInvent International's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.BioInvent Profitablity
BioInvent International's profitability indicators refer to fundamental financial ratios that showcase BioInvent International's ability to generate income relative to its revenue or operating costs. If, let's say, BioInvent International is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, BioInvent International's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of BioInvent International's profitability requires more research than a typical breakdown of BioInvent International's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.16) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.16. Technical Drivers
As of the 29th of November, BioInvent International shows the Mean Deviation of 2.67, downside deviation of 3.2, and Risk Adjusted Performance of 0.0854. BioInvent International technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.BioInvent International Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. BioInvent International middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for BioInvent International. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
BioInvent International Outstanding Bonds
BioInvent International issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BioInvent International uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BioInvent bonds can be classified according to their maturity, which is the date when BioInvent International AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
BioInvent International Predictive Daily Indicators
BioInvent International intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BioInvent International stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
BioInvent International Forecast Models
BioInvent International's time-series forecasting models are one of many BioInvent International's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BioInvent International's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About BioInvent Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how BioInvent International prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BioInvent shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as BioInvent International. By using and applying BioInvent Stock analysis, traders can create a robust methodology for identifying BioInvent entry and exit points for their positions.
BioInvent International AB focuses on the research and development of immunomodulating antibodies for the treatment of cancer in Sweden, Europe, and internationally. The Company was founded in 1997 and is based in Lund, Sweden. BioInvent International operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 68 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding BioInvent International to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance |
All Next | Launch Module |
Additional Tools for BioInvent Stock Analysis
When running BioInvent International's price analysis, check to measure BioInvent International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioInvent International is operating at the current time. Most of BioInvent International's value examination focuses on studying past and present price action to predict the probability of BioInvent International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioInvent International's price. Additionally, you may evaluate how the addition of BioInvent International to your portfolios can decrease your overall portfolio volatility.